Figure 1
From: The potential value of integrated natriuretic peptide and echo-guided heart failure management
From natriuretic peptide driven (without imaging support) to "echo-print" individualized and tailored treatment in heart failure: different echocardiographic fingerprints ("echo-print") have different therapeutic implications. For instance, evidence of pulmonary congestion (right upper panel) through B-lines supports the use of diuretic treatment, whereas the lack of contractile reserve during dobutamine stress echo (right lower panel) discourages the indication to CRT.